| P2093 | author name string | Jae Hyuk Lee | |
| | Seong Young Kwon | |
| | Jung Wook Huh | |
| | Hyeong Rok Kim | |
| P2860 | cites work | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| | In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. | Q34363872 |
| | From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors | Q34978457 |
| | (18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response. | Q36611842 |
| | The role of FDG-PET scans in patients with lymphoma | Q36914696 |
| | PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature | Q37764729 |
| | Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome. | Q37862538 |
| | Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy | Q37918671 |
| | Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT. | Q37991239 |
| | Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis | Q38117128 |
| | The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry | Q40027009 |
| | The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer. | Q43002292 |
| | Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy | Q44700472 |
| | 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation | Q44748398 |
| | Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. | Q45071422 |
| | Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. | Q45160689 |
| | Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0? | Q45937366 |
| | The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. | Q46023482 |
| | Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? | Q46418454 |
| | Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer | Q46809329 |
| | Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery | Q46877940 |
| | Anastomotic leakage after laparoscopic resection of rectal cancer: the impact of fibrin glue | Q47692932 |
| | Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer. | Q51780493 |
| | Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation. | Q53406884 |
| | PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. | Q53506378 |
| | Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: Diffusion-weighted 3 tesla MR imaging | Q60660167 |
| | The effect of preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary rectal carcinoma | Q74635399 |
| | [WHO Classification of digestive tumors: the fourth edition] | Q82351087 |
| | The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation | Q83665710 |
| P433 | issue | 2 | |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | 353-359 | |
| P577 | publication date | 2014-09-03 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer. | |
| P478 | volume | 141 | |